EverQuote (NASDAQ:EVER) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

EverQuote (NASDAQ:EVER) had its target price upped by investment analysts at JPMorgan Chase & Co. from $30.00 to $32.00 in a research note issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 15.36% from the company’s current price.

Several other research firms have also commented on EVER. Zacks Research upgraded EverQuote from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, November 4th. Wall Street Zen cut EverQuote from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 1st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of EverQuote in a research note on Wednesday, October 8th. Finally, Needham & Company LLC raised their target price on shares of EverQuote from $38.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Two research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $34.25.

EverQuote Stock Performance

Shares of NASDAQ EVER opened at $27.74 on Friday. EverQuote has a 1 year low of $16.63 and a 1 year high of $30.03. The firm’s 50 day moving average price is $23.75 and its 200 day moving average price is $24.01. The firm has a market cap of $997.53 million, a P/E ratio of 19.40 and a beta of 0.46.

EverQuote (NASDAQ:EVER) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.13. EverQuote had a return on equity of 38.19% and a net margin of 8.36%.The company had revenue of $173.94 million during the quarter, compared to the consensus estimate of $166.09 million. During the same period in the previous year, the firm posted $0.31 EPS. EverQuote’s revenue was up 20.3% on a year-over-year basis. As a group, equities analysts predict that EverQuote will post 0.72 EPS for the current year.

Insider Transactions at EverQuote

In related news, CEO Jayme Mendal sold 14,360 shares of the stock in a transaction that occurred on Thursday, November 20th. The shares were sold at an average price of $23.55, for a total transaction of $338,178.00. Following the completion of the sale, the chief executive officer owned 452,412 shares of the company’s stock, valued at approximately $10,654,302.60. This represents a 3.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO David Brainard sold 1,291 shares of the firm’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $26.40, for a total transaction of $34,082.40. Following the completion of the transaction, the chief technology officer owned 112,661 shares in the company, valued at $2,974,250.40. The trade was a 1.13% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 58,833 shares of company stock valued at $1,341,247. Insiders own 25.52% of the company’s stock.

Institutional Investors Weigh In On EverQuote

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its position in EverQuote by 6.0% during the 3rd quarter. Vanguard Group Inc. now owns 2,201,338 shares of the company’s stock worth $50,345,000 after purchasing an additional 123,728 shares during the period. Acadian Asset Management LLC raised its position in EverQuote by 1.2% in the second quarter. Acadian Asset Management LLC now owns 866,481 shares of the company’s stock valued at $20,939,000 after purchasing an additional 10,233 shares during the period. Qube Research & Technologies Ltd lifted its stake in shares of EverQuote by 27.3% during the second quarter. Qube Research & Technologies Ltd now owns 800,114 shares of the company’s stock worth $19,347,000 after purchasing an additional 171,787 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of EverQuote by 3.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 727,956 shares of the company’s stock worth $16,648,000 after buying an additional 26,980 shares during the period. Finally, Emerald Advisers LLC grew its stake in shares of EverQuote by 11.2% in the third quarter. Emerald Advisers LLC now owns 689,253 shares of the company’s stock valued at $15,763,000 after buying an additional 69,668 shares in the last quarter. 91.54% of the stock is currently owned by hedge funds and other institutional investors.

EverQuote Company Profile

EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.